Radiopharmacy firm Syncor International reported improving marginson the strength of continued sales growth through the first halfof 1995. Net sales for the six months ended June 30 increased6.1%, to $166.3 million. Net income for the period was $2.3
Radiopharmacy firm Syncor International reported improving marginson the strength of continued sales growth through the first halfof 1995. Net sales for the six months ended June 30 increased6.1%, to $166.3 million. Net income for the period was $2.3 million,compared to $2.8 million in the first half of 1994.
In the second quarter of 1995, net sales increased 1.7% to $83.3million. Net income for the second quarter was $1.3 million, comparedto $700,000 for the same period last year.
Results through June put the company on track to meet Syncor's1995 financial objectives, according to chief executive Gene McGrevin.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.